Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
New Disease-Modifying Therapies and New Challenges for MS.
Absence of mannose-binding lectin in a female with relapsing-remitting multiple sclerosis.
Characterization of autologous mesenchymal stem cell-derived neural progenitors as a feasible source of stem cells for central nervous system applications in multiple sclerosis.
Prospective Examination of Anxiety and Depression Before and During Confirmed and Pseudoexacerbations in Patients With Multiple Sclerosis.
Cystoid macular edema associated with fingolimod use for multiple sclerosis.
Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease.
The olfactory vector hypothesis of neurodegenerative disease: is it viable?
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis.
Connective Tissue and its Growth Factor, CTGF, Distinguish the Morphometric and Molecular Remodeling of the Bladder in a Model of Neurogenic Bladder.
[Cognitive impairment in demyelinating disease].
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.
The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial.
SMAD family proteins: the current knowledge on their expression and potential role in neoplastic diseases.
Incidence of Mood or Anxiety Disorders in Children of Parents with Multiple Sclerosis.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Psychotherapeutic and psychosocial interventions for managing stress in multiple sclerosis: the contribution of mindfulness-based interventions.
Massive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.
Laquinimod Halted MS Disability But Not Relapses
PLEGRIDY™ (peginterferon beta-1a) two-year data confirm maintenance of efficacy and safety in multiple sclerosis patients
Amiloride Hydrochlorothiazide as Treatment of Acute Inflammation of the Optic Nerve
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination.

Pages